STM publisher Elsevier, Netherlands, has announced the appointment of Jay Katzen as Managing Director of its Clinical Decision Support (CDS) group within Elsevier Health Sciences. Katzen will be responsible for all CDS operations and strategy, including product development, marketing, M&A and sales.
Katzen brings more than 23 years of experience in delivering information and workflow solutions to researchers, clinicians, and executives to improve institutional outcomes. Most recently, he was the Managing Director of the Academic and Government Markets unit at Elsevier’s Science & Technology division. In that role, he was responsible for product, marketing, strategy, M&A, and project and portfolio management. He led two acquisitions and delivered the SciVerse platform for scientific search and discovery, which includes SciVerse Hub and Application Marketplace and integrates ScienceDirect, Scopus, and Scirus. In addition, he led the strategy to define the new SciVal suite of solutions and services, enabling Elsevier to enter a new market for performance and planning at universities and government agencies.
Prior to joining Elsevier in 2007, he was the Senior Vice President of Marketing, Business Development and Knowledge Management at Micromedex, the Clinical Decision Support unit of Thomson Reuters.
Elsevier’s Clinical Decision Support solutions offer insight into the business of providing care, in areas from resource and performance management to drug information and clinical data analytics, as well as the tools healthcare organisations need to make better, more informed decisions around care delivery. These solutions enhance workflow and lead to better predictability and better outcomes via evidence-based medicine.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
